PoC testing is in the market today – it is worth approximately US$11.5 billion annually, with percentage growth in double figures and some three-times faster than the total IVD market. Applications to ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. As per the CDC (Centers for Disease ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.